Preview

Педиатрическая фармакология

Расширенный поиск

Дерматологические проявления COVID-19 у детей

https://doi.org/10.15690/pf.v19i2.2398

Полный текст:

Аннотация

В представленной публикации описаны различные дерматологические проявления COVID-19, которые развивались у пациентов детского возраста, описана частота их встречаемости, а также особенности клинической картины. Отдельно рассмотрены высыпания по типу псевдоотморожений как наиболее специфичные среди детской популяции, перенесшей коронавирусную инфекцию. Также представлено описание кожных проявлений при мультисистемном воспалительном синдроме у детей, затронуты вопросы лабораторной диагностики.

Об авторах

В. В. Иванчиков
НИИ педиатрии и охраны здоровья детей НКЦ №2 РНЦХ им. акад. Б.В. Петровского
Россия

Иванчиков Владислав Владимирович.

Москва.

eLibrary SPIN: 1078-5850


Раскрытие интересов:

Отсутствие конфликта интересов, о котором необходимо сообщить



Э. Т. Амбарчян
НИИ педиатрии и охраны здоровья детей НКЦ №2 РНЦХ им. акад. Б.В. Петровского
Россия

Амбарчян Эдуард Тигранович - кандидат медицинских наук, заведующий отделением дерматологии НИИ педиатрии и охраны здоровья детей НКЦ №2 РНЦХ им. акад. Б.В. Петровского.

117593, Москва, Литовский бульвар, д. 1а.

тел.: 8 (915) 400-00-02

eLibrary SPIN: 4878-5562


Раскрытие интересов:

Получение исследовательских грантов от компаний Eli Lilly, Novartis, AbbVie, Pfizer, Amryt Pharma plc, гонораров за научное консультирование от Johnson & Johnson.



А. Д. Кузьминова
НИИ педиатрии и охраны здоровья детей НКЦ №2 РНЦХ им. акад. Б.В. Петровского
Россия

Кузьминова Анастасия Дмитриевна.

Москва.

eLibrary SPIN: 7014-2239


Раскрытие интересов:

Отсутствие конфликта интересов, о котором необходимо сообщить



Список литературы

1. Kabeerdoss J, Pilania RK, Karkhele R, et al. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. 2021;41(1):19-32. doi: https://doi.org/10.1007/s00296-020-04749-4

2. Nuno-Gonzalez A, Martin-Carrillo P, Magaletsky K, et al. Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings. Br J Dermatol. 2021;184(1):184-185. doi: https://doi.org/10.1111/bjd.19564

3. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi: https://doi.org/10.1056/NEJMoa2001017

4. Morris SB, Schwartz NG, Patel P, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450-1456. doi: https://doi.org/10.15585/mmwr.mm6940e1

5. Marzano AV, Cassano N, Genovese G, et al. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. 2020;183(3):431-442. doi: https://doi.org/10.1111/bjd.19264

6. Labe P, Ly A, Sin C, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol. 2020;34(10):e539-e541. doi: https://doi.org/10.1111/jdv.16666

7. Seque CA, Enokihara MMSES, Porro AM, et al. Skin manifestations associated with COVID-19. An Bras Dermatol. 2022;97(1):75-88. doi: https://doi.org/10.1016/j.abd.2021.08.002

8. Tan SW, Tam YC, Oh CC. Skin manifestations of COVID-19: A worldwide review. JAAD Int. 2021;2:119-133. doi: https://doi.org/10.1016/j.jdin.2020.12.003

9. COVID Symptom Study App (archive). In: British Association of Dermatologists. Available online: https://covidskinsigns.com. Accessed on April 17, 2022.

10. Rocha KO, Zanuncio VV, Freitas BAC, et al. “COVID toes”: A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings. Pediatr Dermatol. 2021;38(5):1143-1149. doi: https://doi.org/10.1111/pde.14805

11. Andina D, Noguera-Morel L, Bascuas-Arribas M, et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020;37(3):406-411. doi: https://doi.org/10.1111/pde.14215

12. Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol. 2021;46(3):444-450. doi: https://doi.org/10.1111/ced.14481

13. Nemazee L, Elangasinghe V. A Case of ‘Long Covid Toes' with Associated Cryofibrinogenaemia. In: 20th ESPD Annular Meeting, May 12-14, 2021. On-Line Poster.

14. Volpi S, Picco P, Caorsi R, et al. Type I interferonopathies in pediatric rheumatology. Pediatr Rheumatol Online J. 2016;14(1):35. doi: https://doi.org/10.1186/s12969-016-0094-4

15. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1-13. doi: https://doi.org/10.1016/j.trsl.2020.04.007

16. Gianotti R, Recalcati S, Fantini F, et al. Histopathological Study of a Broad Spectrum of Skin Dermatoses in Patients Affected or Highly Suspected of Infectionby COVID-19intheNorthernPartof Italy: Analysis of the Many Faces of the Viral-Induced Skin Diseases in Previous and New Reported Cases. Am J Dermatopathol. 2020;42(8):564-570. doi: https://doi.org/10.1097/DAD.0000000000001707

17. Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: Part 2. Clin Exp Dermatol. 2021;46(3):451-461. doi: https://doi.org/10.1111/ced.14482

18. Estebanez A, Perez-Santiago L, Silva E, et al. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020;34(6):e250-e251. doi: https://doi.org/10.1111/jdv.16474

19. Young S, Fernandez AP. Skin manifestations of COVID-19. Cleve Clin J Med. 2020 May 14. Online ahead of print. doi: https://doi.org/10.3949/ccjm.87a.ccc031

20. Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-285. doi: https://doi.org/10.1016/j.jaad.2020.04.044

21. Criado PR, Abdalla BMZ, de Assis IC, et al. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/ COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020;69(8):745-756. doi: https://doi.org/10.1007/s00011-020-01370-w

22. de Masson A, Bouaziz JD, Sulimovic L, et al. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France. J Am Acad Dermatol. 2020;83(2):667-670. doi: https://doi.org/10.1016/j.jaad.2020.04.161

23. Ventura-Espejo L, Gracia-Darder I, Escriba-Bori S, et al. Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia. Pediatr Rheumatol Online J. 2021;19(1):104. doi: https://doi.org/10.1186/s12969-021-00586-2

24. Manalo IF, Smith MK, Cheeley J, et al. A dermatologic manifestation of COVID-19: transient livedoreticularis. J Am Acad Dermatol. 2020;83(2):700. doi: https://doi.org/10.1016/j.jaad.2020.04.018

25. Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;16(8):413-414. doi: https://doi.org/10.1038/s41584-020-0448-7

26. Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-1778. doi: https://doi.org/10.1016/S0140-6736(20)31103-X

27. Young TK, Shaw KS, Shah JK, et al. Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic. JAMA Dermatol. 2021;157(2):207-212. doi: https://doi.org/10.1001/jamadermatol.2020.4779

28. Naka F, Melnick L, Gorelik M, Morel KD. A dermatologic perspective on multisystem inflammatory syndrome in children. Clin Dermatol. 2021;39(1):163-168. doi: https://doi.org/10.1016/j.clindermatol.2020.09.003

29. Miller J, Cantor A, Zachariah P, et al. Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases. Gastroenterology. 2020;159(4):1571-1574.e2. doi: https://doi.org/10.1053/j.gastro.2020.05.079

30. Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: Part 3. Clin Exp Dermatol. 2021;46(3):462-472. doi: https://doi.org/10.1111/ced.14483

31. Salian VS, Wright JA, Vedell PT, et al. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies. Mol Pharm. 2021;18(3):754-771. doi: https://doi.org/10.1021/acs.molpharmaceut.0c00608

32. Centers for Disease Control and Prevention. Interim Guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) — Version 2.1. Available online: https://www.cdc.gov/coronavirus/mers/down-loads/Guidelines-Clinical-Specimens.pdf. Accessed on April 17, 2022.

33. Colonna C, Monzani NA, Rocchi A, et al. Chilblain-like lesions in children following suspected COVID-19 infection. Pediatr Dermatol. 2020;37(3):437-440. doi: https://doi.org/10.1111/pde.14210

34. Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-1032. doi: https://doi.org/10.1038/s41591-020-0968-3

35. Cazzato, G., Foti, C., Colagrande, A., et al. Skin Manifestation of SARS-CoV-2: The Italian Experience. J Clin Med. 2021;10(8):1566. doi: https://doi.org/10.3390/jcm10081566

36. Ahmed M, Advani S, Moreira A, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020;26:100527. doi: https://doi.org/10.1016/j.eclinm.2020.100527


Рецензия

Для цитирования:


Иванчиков В.В., Амбарчян Э.Т., Кузьминова А.Д. Дерматологические проявления COVID-19 у детей. Педиатрическая фармакология. 2022;19(2):105-114. https://doi.org/10.15690/pf.v19i2.2398

For citation:


Ivanchikov V.V., Ambarchyan E.T., Kuzminova A.D. COVID-19 Dermatological Manifestations in Children. Pediatric pharmacology. 2022;19(2):105-114. (In Russ.) https://doi.org/10.15690/pf.v19i2.2398

Просмотров: 152


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)